Pioneering diagnostics

bioMérieux Switzerland | Pioneering diagnostics

AKTUELLES

23.10.2023

bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury
24.02.2021

bioMérieux – 2020 Financial Results
27.02.2019

bioMérieux – 2018 Financial Results
13.11.2018

bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking
30.09.2018

bioMérieux – Business review for the nine months ended

MEHR